Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037).
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000633:toxicity; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D003510:Cyclohexanes / Q000008:administration & dosage / Q000633:toxicity; D006801:Humans; D007668:Kidney / Q000187:drug effects; D007962:Leukocytes / Q000187:drug effects; D007970:Leukopenia / Q000139:chemically induced; D008099:Liver / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy*; D009603:Nitroso Compounds / Q000008:administration & dosage* / Q000633:toxicity; D013921:Thrombocytopenia / Q000139:chemically induced; D014508:Urea / Q000008:administration & dosage* / Q000633:toxicity
D000970:Antineoplastic Agents; D003510:Cyclohexanes; D009603:Nitroso Compounds; D014508:Urea